multi-center randomized controlled trial.
Showing 26 - 50 of >10,000
Cataract Trial in Austria, Germany, Netherlands (remote monitoring after cataract surgery)
Recruiting
- Cataract
- remote monitoring after cataract surgery
-
Vienna, Austria
- +5 more
Aug 16, 2022
Gastroenteritis Trial in Japan (Placebo, HIL-214)
Recruiting
- Gastroenteritis
- Placebo
- HIL-214
-
Fukui-Shi, Japan
- +3 more
Aug 18, 2023
Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in
Not yet recruiting
- Liver Transplant; Complications
- +3 more
- multi-kinase inhibitors in combination with bevacizumab
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023
Primary Hypercholesterolemia Trial in Seoul (D377, CKD-331, D086)
Recruiting
- Primary Hypercholesterolemia
- D377
- +5 more
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 12, 2022
Hypercholesterolemia, Dyslipidemia Trial in Seoul (Ezetimibe/Atorvastatin 10/5 mg, Atorvastatin 5mg, Ezetimibe 10mg)
Completed
- Hypercholesterolemia, Dyslipidemia
- Ezetimibe/Atorvastatin 10/5 mg
- +7 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jul 24, 2023
Rheumatoid Arthritis Trial in Ann Arbor, Rochester, Columbus (Mobile Health App)
Recruiting
- Rheumatoid Arthritis
- Mobile Health App
-
Ann Arbor, Michigan
- +1 more
Jan 4, 2023
Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- 5-fu
- +3 more
-
Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023
Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- Intensity Modulated Radiation Therapy
- +3 more
- (no location specified)
Jul 11, 2023
Homonymous Hemianopia Trial in Boston (Multi-Periscopic Prism (MPP) glasses, Fresnel Peripheral Prism (FPP) glasses)
Recruiting
- Homonymous Hemianopia
- Multi-Periscopic Prism (MPP) glasses
- Fresnel Peripheral Prism (FPP) glasses
-
Birmingham, Alabama
- +6 more
Jan 19, 2023
Nasopharyngeal Carcinoma, Radiotherapy; Complications Trial (Intensity Modulated Radiation Therapy, Chemotherapy)
Not yet recruiting
- Nasopharyngeal Carcinoma
- Radiotherapy; Complications
- Intensity Modulated Radiation Therapy
- Chemotherapy
- (no location specified)
Mar 20, 2023
Cancer, Quality of Life, Anxiety Trial in United States (Promoting Resilience in Stress Management (PRISM))
Recruiting
- Cancer
- +6 more
- Promoting Resilience in Stress Management (PRISM)
-
Los Angeles, California
- +4 more
Nov 29, 2022
Transplant Complication Trial (Pooled allogeneic fecal microbiotherapy, Placebo)
Not yet recruiting
- Transplant Complication
- Pooled allogeneic fecal microbiotherapy
- Placebo
- (no location specified)
Feb 27, 2023
Drug-Induced Acute Liver Injury Trial in Shanghai (bicyclol, 25mg/ tablet, polyene phosphatidylcholine capsules, 228mg/
Recruiting
- Drug-Induced Acute Liver Injury
- bicyclol, 25mg/ tablet
- polyene phosphatidylcholine capsules, 228mg/ particle.
-
Shanghai, Shanghai, China
- +1 more
Aug 3, 2022
Advanced Solid Tumors Harboring NTRK Fusion, Primary CNS Tumors Harboring NTRK Fusion Trial in Guangzhou (ICP-723)
Recruiting
- Advanced Solid Tumors Harboring NTRK Fusion
- Primary Central Nervous System Tumors Harboring NTRK Fusion
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Feb 16, 2023
End Stage Renal Disease Trial in Shanghai (regular hemodialysis, hemoperfusion combined with hemodialysis)
Recruiting
- End Stage Renal Disease
- regular hemodialysis
- hemoperfusion combined with hemodialysis
-
Shanghai, Shanghai, ChinaChanghai Hospital
Feb 1, 2023
Diabetes, Type 2, Obesity Trial (endomina®)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Obesity
- endomina®
- (no location specified)
Aug 23, 2022
Post Traumatic Stress Disorder Trial (Intervention C Daridorexant, Intervention C Placebo)
Not yet recruiting
- Post Traumatic Stress Disorder
- Intervention C Daridorexant
- Intervention C Placebo
- (no location specified)
Jul 5, 2023
Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)
Not yet recruiting
- Marginal Zone Lymphoma
- (no location specified)
Nov 6, 2023
Bowel Preparation Trial in Seoul (CTP0301-A, CTP0301-B, Cool prep)
Recruiting
- Bowel Preparation
- CTP0301-A
- +2 more
-
Seoul, Korea, Republic ofTaejoon Pharmaceutical Co., Ltd.
May 21, 2023
Lymphedema Trial in Cairo (Multi-waved Locked System Laser, Cold Compression therapy, complete decongestive therapy)
Completed
- Lymphedema
- Multi-waved Locked System Laser
- +2 more
-
Cairo, EgyptKasr El-Einy Center of Radiation Oncology and Nuclear Medicine,
Jun 16, 2023
Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,
Not yet recruiting
- Breast Cancer Invasive
- +3 more
- Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
- Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023
Post Traumatic Stress Disorder Trial (Intervention B Vilazodone Hydrochloride, Intervention B Placebo)
Not yet recruiting
- Post Traumatic Stress Disorder
- Intervention B Vilazodone Hydrochloride
- Intervention B Placebo
- (no location specified)
Jul 5, 2023
Post Traumatic Stress Disorder Trial (Intervention A Fluoxetine HCl, Intervention A Placebo)
Not yet recruiting
- Post Traumatic Stress Disorder
- Intervention A Fluoxetine HCl
- Intervention A Placebo
- (no location specified)
Jul 5, 2023
Stone, Kidney Trial in Mansoura (Group A (p-PCNL) procedure, Group B (s-ECIRS) procedure)
Recruiting
- Stone, Kidney
- Group A (p-PCNL) procedure
- Group B (s-ECIRS) procedure
-
Mansoura, Outside U.S./Canada, EgyptMansoura Urology and Nephrology Center
Jul 13, 2022
Atrial Fibrillation, HFpEF - Heart Failure With Preserved Ejection Fraction Trial (Radiofrequency catheter ablation (RFCA),
Not yet recruiting
- Atrial Fibrillation
- HFpEF - Heart Failure With Preserved Ejection Fraction
- Radiofrequency catheter ablation (RFCA)
- Medical Therapy
- (no location specified)
Nov 5, 2023